Reprogramming and Epigenetic Modifications: Unraveling the Role of Histone Lactylation in Atherosclerosis

Lactylation links cellular metabolism to histone regulation and nonhistone protein function; however, its functional consequences in atherosclerosis depend on the modified substrate, target residue, cell type, and disease stage. This narrative review distinguishes direct atherosclerosis evidence from cardiovascular but non-atherosclerosis evidence and cross-disease mechanistic context, framing mechanistic claims accordingly. Direct evidence in atherosclerosis implicates several pathogenic pathways, including endothelial H3K18 lactylation at NF-κB pathway and SNAI1 promoters, SLC22A6- and ACSS1-driven H3K9 lactylation, lactate- and AARS1-dependent FOXO1 lactylation under atheroprone flow, H4K12 lactylation at CDKN1A during endothelial senescence, and an H3K18 lactylation–METTL3 axis in macrophage ferroptosis. Conversely, direct evidence also supports atheroprotective pathways, notably nonhistone MeCP2 K271 lactylation in endothelial cells and macrophages. Observations from myocardial repair, valvular and medial calcification, aortic aneurysm, pulmonary hypertension, and oncology provide mechanistic context rather than direct proof of plaque-specific biology. Furthermore, we examine the interplay between lactylation and acetylation, methylation, and RNA modifications—including scenarios where lactylation functions upstream of acetylation—and critically evaluate the capabilities and limitations of current analytical methods. Key methodological considerations include lactyl-donor stoichiometry and site occupancy; antibody cross-reactivity; resolution of L-lactyl, D-lactyl, and carboxyethyl lysine isomers; mass-spectrometric site localization; chromatin profiling against matched acetylation controls; and stable-isotope tracing. Finally, we propose an integrative translational framework that pairs peripheral mononuclear cell and plaque sampling with single-cell and spatial multi-omics, strictly distinguishing lactate sensing from site-specific protein lactylation detection. To date, no clinically validated lactylation biomarker or lactylation-targeted therapy exists for atherosclerosis, and lactate abundance cannot be conflated with protein lactylation. Clinical translation ultimately requires site-specific causal validation in plaque-relevant models and prospective human cohorts.

Authors

Institutions

Publication Details

Journal
Biomolecules
Published
2026-11-19
DOI
https://doi.org/10.3390/biom16111681
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Reprogramming and Epigenetic Modifications: Unraveling the Role of Histone Lactylation in Atherosclerosis

Rifang Gu, Xuqiang Nie, Xu Ya, Lele Liu et al.
Biomolecules
Epigenetics and DNA Methylation
article

Reprogramming and Epigenetic Modifications: Unraveling the Role of Histone Lactylation in Atherosclerosis

Rifang Gu, Xuqiang Nie, Xu Ya, Lele Liu, Taotao Guoyang, Fengqin Luo, Ming Tang, Caozhen Wu, Xiuying Guo, Xiaoqin Mi
article en

Abstract

Lactylation links cellular metabolism to histone regulation and nonhistone protein function; however, its functional consequences in atherosclerosis depend on the modified substrate, target residue, cell type, and disease stage. This narrative review distinguishes direct atherosclerosis evidence from cardiovascular but non-atherosclerosis evidence and cross-disease mechanistic context, framing mechanistic claims accordingly. Direct evidence in atherosclerosis implicates several pathogenic pathways, including endothelial H3K18 lactylation at NF-κB pathway and SNAI1 promoters, SLC22A6- and ACSS1-driven H3K9 lactylation, lactate- and AARS1-dependent FOXO1 lactylation under atheroprone flow, H4K12 lactylation at CDKN1A during endothelial senescence, and an H3K18 lactylation–METTL3 axis in macrophage ferroptosis. Conversely, direct evidence also supports atheroprotective pathways, notably nonhistone MeCP2 K271 lactylation in endothelial cells and macrophages. Observations from myocardial repair, valvular and medial calcification, aortic aneurysm, pulmonary hypertension, and oncology provide mechanistic context rather than direct proof of plaque-specific biology. Furthermore, we examine the interplay between lactylation and acetylation, methylation, and RNA modifications—including scenarios where lactylation functions upstream of acetylation—and critically evaluate the capabilities and limitations of current analytical methods. Key methodological considerations include lactyl-donor stoichiometry and site occupancy; antibody cross-reactivity; resolution of L-lactyl, D-lactyl, and carboxyethyl lysine isomers; mass-spectrometric site localization; chromatin profiling against matched acetylation controls; and stable-isotope tracing. Finally, we propose an integrative translational framework that pairs peripheral mononuclear cell and plaque sampling with single-cell and spatial multi-omics, strictly distinguishing lactate sensing from site-specific protein lactylation detection. To date, no clinically validated lactylation biomarker or lactylation-targeted therapy exists for atherosclerosis, and lactate abundance cannot be conflated with protein lactylation. Clinical translation ultimately requires site-specific causal validation in plaque-relevant models and prospective human cohorts.

BiomoleculesVol. 16(11)
St. Jude Children's Research Hospital (US), Zunyi Medical University (CN)
Epigenetics and DNA Methylation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon